CSF1R and cancer: Blockade of colony-stimulating factor-1 (CSF-1) or its receptor CSF-1R represents a selective approach to manipulate macrophages in cancer patients [15] and some studies have explored this new therapeutic axis in some hematologic malignancies [16–19].